Dyadic Applied BioSolutions expands collaboration with Fermbox Bio.

Dyadic Applied BioSolutions has expanded its collaboration with Fermbox Bio, a biotech research & manufacturing company. The agreement enables Fermbox to manufacture and commercialize an expanding portfolio of Dyadic-developed proteins and enzymes using the Dapibus and C1 expression systems. Dyadic will co-commercialize these products, broadening the range of products, platforms, and commercial opportunities for both companies. This partnership builds on their longstanding relationship and aims to deliver sustainable bio-based products through precision fermentation and advanced biotechnology tools.